- Home
- Publications
- Publication Search
- Publication Details
Title
Ebola virus disease: current vaccine solutions
Authors
Keywords
-
Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 71, Issue -, Pages 27-33
Publisher
Elsevier BV
Online
2021-04-19
DOI
10.1016/j.coi.2021.03.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis
- (2020) Ravi Potluri et al. PLoS One
- To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
- (2020) Amanda N. Pinski et al. Microorganisms
- Ebola virus disease
- (2019) Denis Malvy et al. LANCET
- ‘Make Ebola a thing of the past’: first vaccine against deadly virus approved
- (2019) Ewen Callaway NATURE
- The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
- (2018) Ellen Suder et al. Human Vaccines & Immunotherapeutics
- Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?
- (2018) Angela Huttner et al. Expert Review of Vaccines
- Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
- (2017) Scott A. Halperin et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- The Ebola outbreak, 2013–2016: old lessons for new epidemics
- (2017) Cordelia E. M. Coltart et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors
- (2012) Xinkui Fang et al. VACCINE
- Progress in filovirus vaccine development: evaluating the potential for clinical use
- (2010) Darryl Falzarano et al. Expert Review of Vaccines
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
- (2008) Thomas W. Geisbert et al. VACCINE
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started